TestCard
TestCard is a UK digital health platform that uses proprietary computer vision to turn camera-enabled smartphones into clinical-grade diagnostic scanners for lateral flow and urine dip tests, serving NHS trusts, pharmacies (Superdrug), OEM partners (Roche), research organisations, and consumers via its ClearScreen app.
- Company typePrivate
- Founded2017
- HeadquartersScarborough, United Kingdom
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What TestCard does
TestCard is a UK-based digital health platform company founded in 2017, headquartered in Scarborough, that converts camera-enabled smart devices into clinical-grade diagnostic scanners using proprietary computer vision software. The platform reads, records, and reports lateral flow and urine dip test results through a three-step Scan-Analyse-Integrate workflow. The company operates three product lines: ClearScreen for clinical settings, an At-Home Testing consumer solution, and Research Solutions for organisations such as Yorkshire Cancer Research and Cancer Research UK. The company is not available for sale in the United States and serves UK and European markets.
The underlying technology combines a mobile application (running on camera-enabled devices) with computer vision analysis software that produces objective test readings. Integrations are delivered via unidirectional middleware connections that avoid direct access to Electronic Medical Systems, and no patient data is stored within the app itself. TestCard has embedded its platform technology into the Roche Cobas Pulse device, enabling OEM distribution alongside its direct enterprise deployments with NHS trusts including Guy's and St Thomas' (GSTT).
TestCard operates a multi-channel go-to-market spanning enterprise sales to NHS trusts, pharmacy distribution (Superdrug), direct-to-consumer at-home testing, and OEM licensing to hardware manufacturers. Revenue streams include software licensing/subscription arrangements with NHS and clinical partners, platform technology licensing (e.g., Roche), and direct-to-consumer at-home testing. Pricing is not publicly disclosed. The company has 11-50 employees and has raised approximately $19M in disclosed funding across multiple rounds since 2017, with West Hill Capital as the most active institutional investor.
TestCard firmographics
Firmographics- Name
- TestCard
- Legal name
- TestCard
- Website
- https://TestCard.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- TestCard is a UK digital health platform that uses proprietary computer vision to turn camera-enabled smartphones into clinical-grade diagnostic scanners for lateral flow and urine dip tests, serving NHS trusts, pharmacies (Superdrug), OEM partners (Roche), research organisations, and consumers via its ClearScreen app.
- Ownership category
- akta.pro rank
TestCard industry classification
Industry- Product category
- Digital Diagnostics Software
- NAICS
- Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK)
Keywords
Where TestCard is headquartered
LocationHeadquarters
- HQ city
- Scarborough
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
TestCard business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain
Revenue model
- Clinical Software Licensing: TestCard provides the ClearScreen app and platform technology to NHS trusts and clinical partners, likely through licensing or subscription arrangements for the software solution.
- Platform Technology Licensing: TestCard licenses its platform technology to hardware manufacturers like Roche for deployment on devices such as the Cobas Pulse, generating licensing revenue.
- At-Home Testing Services: Direct-to-consumer at-home testing solutions providing diagnostic accuracy, ease of use, affordability and treatment options.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels2 records
TestCard product offering
Product offeringCore offering
TestCard develops a digital platform technology that converts camera-enabled smart devices into clinical-grade scanners for the reading, recording, and reporting of diagnostic test results. Its core offering is the ClearScreen mobile application, which uses proprietary computer vision to perform lateral flow and urine dip test analysis, alongside at-home self-testing and research-data solutions.
Product overview
TestCard is a digital platform technology that turns camera-enabled smart devices into clinical-grade scanners for accurate reading, recording, and reporting of diagnostic test results. The platform operates as a unified system consisting of three core offerings: ClearScreen (clinical-grade lateral flow and urine dip reading solution for NHS trusts and clinical partners), At-Home Testing (self-testing platform for consumers), and Research Solutions (technology for research organizations providing objective test results and data records). The platform's core workflow involves three steps: Scan (user performs test with smart device support), Analyse (computer vision software reads test results), and Integrate (results are shared digitally with healthcare providers, pharmacies, or integrated into electronic patient records).
Differentiator
Problem solved
Functional benefit
Brands
- ClearScreen: Digital scanning app for lateral flow and urine dip reading, recording, and reporting solution for clinical settings
Products and services
- ClearScreen A clinical-grade lateral flow and urine dip reading, recording, and reporting solution delivered via a mobile application running on camera-enabled devices. It is targeted at NHS trusts and clinical partners for point-of-care diagnostic testing, with simple implementation and low deployment cost.
- At-Home Testing A consumer self-testing platform enabling at-home diagnostic testing with accuracy, ease of use, affordability, and treatment options. It also functions as a route to pre-procedure screening for clinical use.
- Research Solutions Technological solutions for research organizations, supplying instant, objective test results and digital data records to support clinical and cancer research applications.
Companies that use TestCard
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles5 records
TestCard technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature3 records
TestCard partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- NHS TrustscoreTestCard services with key NHS trusts to provide ClearScreen, an accurate and fast lateral flow and urine dip reading, recording, and reporting solution. Implementation includes in-person and remote support during deployment and for the life of the solution.
- RochecoreTestCard integrates its platform technology into Roche hardware, specifically the deployment of diagnostic technology onto the Roche Cobas Pulse device for point-of-care testing.
- Yorkshire Cancer ResearchminorResearch partnership at the forefront of cancer research where TestCard provides technological solutions for vital research, supplying instant, objective test results and data records.
- GSTT (Guy's and St Thomas' NHS Foundation Trust)coreClinical partnership for deployment of ClearScreen diagnostic testing solution in hospital settings.
- SuperdrugminorPharmacy partnership for distribution and delivery of point-of-care diagnostic testing services.
- Cancer Research UKminorCharitable partnership providing technological solutions for cancer research, supporting vital research with instant, objective test results and data records.
Scale indicators1 record
Recent moves3 records
Expansion highlights5 records
TestCard competitors and assessment
Company assessmentDirect peers
- Healthy.io: Healthy.io turns smartphone cameras into clinical-grade urinalysis readers via Dip.io, directly mirroring TestCard's ClearScreen approach for at-home and point-of-care urine dip testing. Both companies sell into health systems and pharmacies and target lay users without specialised hardware.
- Scanwell Health: Scanwell Health builds smartphone-based diagnostic tests, including at-home UTI lateral flow tests read through a mobile app. It is a direct competitor in the connected, app-mediated lateral flow and at-home diagnostics space.
Broad incumbents
- LumiraDx: LumiraDx is a point-of-care diagnostics platform combining a connected device with a broad menu of immunoassays and chemistry tests. It competes with TestCard on the point-of-care diagnostic workflow but via proprietary hardware rather than a smartphone-first approach.
- Cue Health: Cue Health offers a connected, cartridge-based diagnostic platform for at-home and clinical use. It overlaps with TestCard in bringing consumer-grade diagnostic testing into connected digital workflows, though via dedicated hardware.
- Color Health: Color Health operates a large-scale digital diagnostics platform focused on genetic and infectious disease testing, integrated with health systems and employers. It is a broader incumbent in connected, software-mediated diagnostics workflows.
Regional players
- Abingdon Health: Abingdon Health is a UK-based lateral flow assay developer and contract manufacturer. It is a UK regional peer sitting in the same lateral flow value chain and serving overlapping NHS and diagnostic customers.
- DnaNudge: DnaNudge is a UK-based consumer and clinical DNA testing company using its own lab-on-a-chip platform. It is a UK regional peer combining diagnostics hardware with consumer-facing digital interfaces, similar to TestCard's smartphone-driven model.
Emerging players
- Visby Medical: Visby Medical develops single-use, instrument-free PCR diagnostic devices for point-of-care infectious disease testing. It is an emerging player addressing the same point-of-care diagnostic use cases with a different technology modality.
- Ellume: Ellume builds connected digital diagnostic tests, most notably for influenza and COVID-19, pairing a single-use cartridge with a smartphone app. It overlaps with TestCard in connected consumer diagnostics but with a cartridge-based assay.
Others
- Babylon Health: Babylon Health is a UK-based digital health platform offering AI-driven triage and remote consultations. While not a diagnostic reader, it is an adjacent ecosystem participant integrating with NHS pathways similar to those TestCard targets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
TestCard social profiles
Digital presenceTestCard financial estimates
Financial estimateRevenue estimate
Valuation estimate
TestCard leadership team
Management profileNumber of profiles
Profiles7 records
TestCard funding detail
Funding detailFunding overview
Funding rounds7 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TestCard M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TestCard
What does TestCard do?
TestCard develops a digital platform technology that converts camera-enabled smart devices into clinical-grade scanners for the reading, recording, and reporting of diagnostic test results. Its core offering is the ClearScreen mobile application, which uses proprietary computer vision to perform lateral flow and urine dip test analysis, alongside at-home self-testing and research-data solutions.
Is TestCard a public or private company?
TestCard is a private company. It is classified as venture growth investor backed and is currently operating.
When was TestCard founded?
TestCard was founded in 2017. It employs 11 to 50 people.
Where is TestCard based?
TestCard is headquartered in Scarborough, United Kingdom, in the Europe region.
How does TestCard make money?
Three revenue lines are on record. Clinical Software Licensing is the primary driver. The others are platform Technology Licensing and at-Home Testing Services.
Who are TestCard's main competitors?
Direct peers on record are Healthy.io and Scanwell Health. Broad incumbents are LumiraDx, Cue Health and Color Health. Regional players are Abingdon Health and DnaNudge. Emerging players are Visby Medical and Ellume. Babylon Health is listed as an others.
Does TestCard have an API?
No public API is recorded for TestCard.
What industry is TestCard in?
TestCard's product category is Digital Diagnostics Software. Its primary akta.pro industry code is HLACAPAK, Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices). Its NAICS code is 3345 and its SIC code is 3841.